Senior Manager, HTA Value & Evidence (HV&E), PCVs (Pneumococcal Conjugate Vaccines)

As a leading biopharmaceutical company, Pfizer is dedicated to the discovery and delivery of high value therapies across a variety of disease areas. It is our mission to bring innovative medicines to patients that significantly improve their lives, and our priority is to ensure patients have access to these medicines. The HTA, Value and Evidence is responsible for ensuring patients have affordable, timely access to medicines and vaccines by advancing innovative value and evidence solutions — to inform healthcare decision-making.

ROLE SUMMARY

The senior manager, HTA, Value & Evidence (HV&E) for PCVs (Pneumococcal Conjugate Vaccines) will report to and support the HV&E PCV Team Lead.  This role will lead the development and execution of high-quality HEOR studies to achieve optimal recommendation and reimbursement for Pfizer pneumococcal vaccines. The senior manager will be part of the Global Access and Value (GAV) organization and will collaborate with our Global Access Strategy and Pricing (GASP), medical, commercial and policy stakeholders at every stage of development through launch to ensure there is a single and coordinated view on strategy and delivery from GAV to the business. As a strategic partner this role will be focused on generating and communicating robust evidence demonstrating the value of Pfizer’s vaccine portfolio to internal and external stakeholders.

ROLE RESPONSIBILITIES

• Lead development and execution of strategic HV&E activities to support launch preparation both inline and pipeline vaccines with a focus on IDM countries:
  • Contribute to development of the Global Value & Evidence Strategy in close partnership with PHI and cross-functional teams
  • Lead on execution of scientifically robust studies to support health economic models and value propositions, with a focus on ex-US markets
  • Support and train Country Health & Value colleagues in their local adaptations of Global health economic models
  • Execute cross-functional evidence generation studies and projects to demonstrate the value proposition catered to diverse stakeholders (regulators, payers, patients, physicians, and policy makers)
  • Develop new and update existing PHI tools including strategy documents, evidence blueprints, economic models, scenario analyses, global value dossiers (GVDs), and innovative tools to support value proposition
  • Develop and design real-world evidence generation plans to fill key data gaps, with a focus on ex-US markets

Develop data dissemination plans and communicate new evidence to stakeholders via publications and conference publications in a timely manner The HTA, Value & Evidence Director will also be expected to:

• Develop effective processes and ways of working to support collaboration with key internal stakeholder groups (e.g., medical, clinical, commercial, etc.)
• Identify new opportunities for value creation based on an understanding of health care systems and the potential benefits of Pfizer vaccines
• Support development of innovative approaches to evidence generation that meet payer needs and integrate these with the needs of other customers
• Prepare for value story and cost effectiveness modeling content to support vaccine technical committee recommendations

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with all levels of stakeholders to achieve meaningful outcomes and create business impact.

• Graduate degree minimum required (i.e., MBA, MPH, MSc or PharmD / PhD) and 5+ years of experience required with MSc/MPH/MBA degree; 1+ year of experience required with PharmD/PhD in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)
• Demonstrated in depth understanding of fundamental health services research methods and tools including but not limited to:
  • Health economics
  • Cost-effectiveness / budgetary impact modeling
  • Patient reported outcomes measures
  • Real world evidence studies
  • Epidemiology
  • Statistics
• Strong interpersonal skills and evidence of teamwork in a matrix environment
• Ability to understand, synthesize, and summarize complex topics is required
• Excellent oral and written English communication skills are required
• Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly
• An “execution mindset” focused on getting things done quickly and simply
• Demonstrated ability to manage multiple projects involving complex processes, significant budget, competing deadlines, and ra